CADTH | Evidence Driven
CADTH | Evidence Driven

Positron Emission Tomography–Computed Tomography for Cardiovascular Indications: Diagnostic Accuracy, Clinical Utility, Cost-Effectiveness, and Guidelines

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1244-000
Final Biosimilar Summary Dossier Issued:

Question


  1. What is the diagnostic test accuracy of positron emission tomographycomputed tomography (PET-CT) in patients with cardiac sarcoidosis, prosthetic vascular graft infection, or infective    endocarditis?

  2. What is the clinical utility of PET-CT in patients with cardiac sarcoidosis, prosthetic vascular graft infection, or infective endocarditis?

  3. What is the cost-effectiveness of PET-CT in patients with cardiac sarcoidosis, prosthetic vascular graft infection, or infective endocarditis?

  4. What are the evidence-based guidelines regarding the use of PET-CT in patients with cardiac sarcoidosis, prosthetic vascular graft infection, or infective endocarditis?


Key Message

Three systematic reviews (two with meta-analysis), one meta-analysis, and seven non-randomized studies were identified regarding positron emission tomographycomputed tomography in patients with cardiac sarcoidosis, prosthetic vascular graft infection, or infective endocarditis. No relevant evidence-based guidelines were identified.


Files

Positron Emission Tomography–Computed Tomography for Cardiovascular Indications: Diagnostic Accuracy, Clinical Utility, Cost-Effectiveness, and Guidelines Rapid Response August 13, 2018 View PDF

Related Content

Last Updated : August 13, 2018